In 2016 Bladder Cancer Canada funded the first study to comprehensively produce quality indicators for bladder cancer.
Over time these benchmarks will provide the opportunity to improve consistency of care and better outcomes for patients. Though developed in Canada, these indicators can potentially be used around the world.
Read the overview below:
Leave a Comment